Edward Cho
Surgical Oncology · Tulsa, OKNPI 1336453406
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (46.7%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by AbbVie at 49.2% of the total. Reporting peaked in 2019 at $4,776 and has fallen 59.5% since, to $1,933 in 2024.
Across 137 payments — averaging $60.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Intuitive Surgical$1K
- Conmed Corporation$800
- Davol Inc.$402
- Sirtex Medical Inc$247
- Johnson & Johnson$176
- plus $1K from 26 others
What the payments were for
- Consulting fees$80010%
- Travel & lodging$3,85547%
- Food & beverage$3,59544%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 39 | $4,061 |
| Intuitive Surgical | 7 | $1,091 |
| Conmed Corporation | 1 | $800 |
| Davol Inc. | 19 | $402 |
| Sirtex Medical Inc | 3 | $247 |
| Johnson & Johnson | 7 | $176 |
| Abbott | 1 | $160 |
| Nestle Healthcare Nutrition Inc. | 7 | $138 |
| Novocure Inc. | 1 | $122 |
| Smith+Nephew | 8 | $117 |
| Angiodynamics, Inc. | 2 | $113 |
| Curium US LLC | 5 | $111 |
| Medtronic | 3 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $66 |
| Fresenius Kabi USA, LLC | 3 | $65 |
| Baxter Healthcare | 3 | $65 |
| Potrero Medical, Inc. | 2 | $58 |
| Merck | 4 | $53 |
| Lexicon Pharmaceuticals, Inc. | 3 | $51 |
| Vivus LLC | 3 | $42 |
| Shire North American Group Inc | 2 | $41 |
| Biom'up France SAS | 1 | $26 |
| Covidien LP | 2 | $25 |
| Acacia Pharma Inc | 1 | $19 |
| Tersera Therapeutics LLC | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Levita Magnetics International Corp | 1 | $16 |
| Mallinckrodt Enterprises LLC | 1 | $14 |
| KCI USA, Inc. | 1 | $13 |
| Acell, Inc. | 1 | $12 |
| Bolder Surgical LLC | 1 | $9 |
| Reprise Biomedical, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few surgical oncology providers in Oklahomato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 58 | $184 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Tulsa
- John BergquistTulsa$29K
- Mohd QutobTulsa$11K
- Laurie FlynnTulsa$3K
- Issac KrileyTulsa$878
- Erica HillTulsa$509
- Huan VuTulsa$345
- Sara SuthersOklahoma City$2K
- Brittany MathiasOklahoma City$1K
- William DooleyOklahoma City$679
- Tara ChandranNorman$648
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.